Key facts
- Parol’s last known valuation is $5.6M (Aug 2022).
- It has raised $1.8M; the latest was Early Stage VC ($1.3M) in Dec 2024.
- Notable investors include Ana Cinca, Cleverage Venture Capital, GapMinder Venture Partners, Marius Istrate, Mălina Platon — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Parol
- ·The full record, as it builds
Funding rounds
No funding rounds for Parol are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Parol
Developer of an AI medical management platform designed to help doctors and medical clinics take better care of patients. The company's tool transcribes in real-time the conversation between the doctor and the patient in Romanian and English, detects the change of speakers, and automatically fills in documents such as the medical record, enabling users to easily manage a patient's medical history and give them access to better treatment.
- Sector
- Healthcare
- HQ
- Bucharest, Romania
- Founded
- 2020
- Employees
- 11
- Website
- parol.app/
- Ownership
- Privately Held (backing)
Parol doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Parol shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Parol in its N-PORT filings yet. We sweep new filings monthly.